KDM1A and cancer: The inhibition of LSD1 activity with a small chemical inhibitor markedly decreased aggressive cancer cell phenotype and stem cell features, as a result of which LSD1 inhibition has attracted considerable attention as a novel therapeutic strategy for cancer treatment32–35.